29.40

0.38% 0.11

Pre-market: 29.40

Biodesix Inc (BDSX)

Overview News Price History Option Chain Financials Discussions Forecast

Biodesix Inc stock is traded at $29.40, with a volume of 120.53K. It is up +0.38% in the last 24 hours and up +15.79% over the past month. Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Previous Close:

$29.29

Open:

$29.22

24h Volume:

120.53K

Relative Volume:

1.23

Market Cap:

$310.20M

Revenue:

$96.10M

Net Income/Loss:

$-31.96M

P/E Ratio:

-7.3013

EPS:

-4.0267

Net Cash Flow:

$-25.27M

1W Performance:

+2.05%

1M Performance:

+15.79%

6M Performance:

+89.19%

1Y Performance:

+250.42%

1-Day Range:

$28.81

$31.35

1-Week Range:

$27.56

$31.35

52-Week Range:

$5.26

$31.35

Biodesix Inc Stock (BDSX) Company Profile

Name

Biodesix Inc

Sector

Healthcare (1068)

Industry

Diagnostics & Research (49)

Phone

303-417-0500

Address

919 WEST DILLON ROAD, LOUISVILLE

Employee

334

Twitter

Next Earnings Date

2026-11-02

Latest SEC Filings

BDSX's Discussions on Twitter

Compare BDSX vs TMO, DHR, NTRA, A, IQV

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BDSX Biodesix Inc	29.40	310.20M	96.10M	-31.96M	-25.27M	-4.0267
TMO Thermo Fisher Scientific Inc	678.39	250.83B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	223.77	157.31B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	408.79	58.92B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	172.84	48.73B	7.23B	1.41B	1.09B	4.979
IQV Iqvia Holdings Inc	275.02	45.27B	16.63B	1.39B	2.12B	8.0674

Biodesix Inc Stock (BDSX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-27-26	Upgrade	William Blair	Mkt Perform → Outperform
May-14-25	Downgrade	William Blair	Outperform → Mkt Perform
Sep-16-24	Initiated	Scotiabank	Sector Outperform
Jul-26-24	Initiated	Craig Hallum	Buy
May-13-24	Initiated	TD Cowen	Buy
May-03-24	Initiated	Lake Street	Buy
Nov-17-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-23-20	Initiated	BTIG Research	Buy
Nov-23-20	Initiated	Canaccord Genuity	Buy
Nov-23-20	Initiated	Morgan Stanley	Overweight
Nov-23-20	Initiated	William Blair	Outperform

View All

Biodesix Inc Stock (BDSX) Latest News

Sep 24, 2026

Biodesix, Inc. Advances Two Complementary Approaches to Molecular Residual Disease Monitoring - marketscreener.com

Sep 24, 2026

Biodesix Advances MRD Monitoring Programs With Bio-Rad and Thermo Fisher - Yahoo Finance

Sep 24, 2026

Biodesix advances MRD testing programs with Bio-Rad, Thermo Fisher - Investing.com

Sep 24, 2026

Biodesix Announces Progress on Tumor-Informed and Tumor-Naïve MRD Programs with Bio-Rad and Thermo Fisher - Quiver Quantitative

Sep 24, 2026

Biodesix Advances Two Complementary Approaches To Molecular Residual Disease (Mrd) Monitoring - TradingView

Sep 24, 2026

After cancer treatment, monitoring may reach patients without tumor tissue - Stock Titan

Sep 24, 2026

Sep 20, 2026

Wall Street Analysts Think Biodesix (BDSX) Could Surge 31.91%: Read This Before Placing a Bet - Eastern Progress

Sep 20, 2026

Sep 18, 2026

Biodesix Stock Price Forecast. Should You Buy BDSX? - StockInvest.us

Sep 18, 2026

Biodesix (BDSX) Stock Gets Fair Value Boost On Revenue And Margin Optimism - Yahoo Finance

Sep 18, 2026

Sep 15, 2026

Biodesix Inc (NASDAQ: BDSX) Stock Price, News & Analysis - kalkine.ca

Sep 15, 2026

Sep 14, 2026

Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings - Stock Titan

Sep 14, 2026

Sep 11, 2026

A Look at Biodesix Inc (BDSX) After 3.5% Gain -- GF Value $21.14 vs Price $26.96 - GuruFocus

Sep 11, 2026

Opaleye Management Inc. Cuts Position in Biodesix, Inc. $BDSX - marketbeat.com

Sep 11, 2026

Sep 10, 2026

Biodesix: Growing Fast While Trading Below Many Diagnostics Peers (NASDAQ:BDSX) - Seeking Alpha

Sep 10, 2026

Sep 07, 2026

Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Recommendation of "Moderate Buy" by Analysts - marketbeat.com

Sep 07, 2026

BlackRock Inc. Invests $970,000 in Biodesix, Inc. $BDSX - marketbeat.com

Sep 07, 2026

What Makes Biodesix, Inc. (BDSX) a Strong Momentum Stock: Buy Now? - Eastern Progress

Sep 07, 2026

Sep 03, 2026

Biodesix to Participate in Upcoming Investor Conferences - The Manila Times

Sep 03, 2026

Sep 02, 2026

BioDesix (NASDAQ:BDSX) Passes Minervini Trend Template but Setup Quality Remains Weak - ChartMill

Sep 02, 2026

Aug 31, 2026

Wall Street Analysts See a 26.72% Upside in Biodesix (BDSX): Can the Stock Really Move This High? - Yahoo Finance

Aug 31, 2026

Aug 26, 2026